set to surge oversold with huge potential, page-4

As a long suffering shareholder of HGR, I think we're getting way ahead of ourselves here about the excitement of the pending Chinese order

A 1 million annual order from the Chinese for HGR's test kit at (say) $10 per kit (and that's probably optimistic given the currency differences and an expected "volume discount" ) would suggest around $10M in sales. At a decent net profit margin of say 15%, that would imply extra earnings for HGR of around $1.5M or about $.008 cents per share. Given the multiples in this sector, one would guess (back of the envelope calculation) that the shares should be valued at around 7 cents a share.... but that excludes any nasty surprises on extra contract costs, written down R&D, amortisation etc.

I'm hopefull these Chinese sales eventuate--and soon--but I think we're a long long way off of seeing an HGR share price anything above 10 cents, let alone 30 cents.